Furthermore, accumulating evidence indicates that p53 is also tightly involved in the regulation of ferroptotic cell death, with emerging data indicating that its mutational status also affects the sensitivity of cancer cells to pro-ferroptotic chemotherapeutic drugs [55]. This evidence concerns the gene TP53 and cancer.